Blog / Archives
Rayno Life Science Portfolio 2010: Biopharmaceuticals
Exelixis (EXEL) added as speculative buy at $3.30 on 9/2/10 Update: Portfolio rebalancing below but we are still in a bearish mode with small cap biotech. The brief rally spurred by a potential...
Rayno Life Science Portfolio : Diagnostics and Tools, Quidel and Celera
Quidel (QDEL) was up 7.9% yesterday to $12.13 on volume of 375k shares. This stock is now under review and is a value buy in the $12 range. Quidel bought Diagnostic Hybrids for for $131M in Q1...
Immucor(BLUD) Profits Up but Stock Down 8 %
Immucor (BLUD) a global leader in providing instrument-reagent systems to the blood transfusion industry delivered more than expected financial results for the 3rd Quarter of fiscal 2010 ended...
Gene Patent Ruling stalls Biotech Rally-Myriad (MYGN) down 4.9%
US Judge invalidates cancer gene patents Intellectual Property (IP) is the raw material for the creation of biotech companies. Without an invention covered by a robust patent portfolio, venture...
Market Reversal Today -Be Cautious
The market reversed today about 1:30p EDT as positive Bernanke chat yielded to Trichet and the Baklava Bailout. The NASDAQ Comp was up to the 2430 range then closed at 2397. The Rayno Life Science...
2009-2010 Life Sciences Portfolio
The Raygent Model Portfolio was created in February 2009 and will be updated by the end of March 2010.The 14 month YTD performance is up 25%. New buys over past four months were Sequenom (SQNM) and...
Healthcare Stocks up-Market absorbs Reform
Healthcare and biotech stocks were up today as expected following passage of the historic reform bill. Although there is a considerable amount of work to be done in enabling the historic...
2010 Life Science Portfolio-Look at Immucor (BLUD)
We are currently rebalancing our 2010 Life Science Portfolio (See under "Articles" at top of WEB site). We are updating our Diagnostics and Genomics Model Portfolio as follows: Our winners for a 14...
Sequenom (SQNM) Catching Bids at $5.75
Sequenom is finding price support today at $5.75, volume of 4.6M at 1p, after a severe three day downdraft triggered by their earnings release. Net loss for Q4 was $18.4M on Revenues of $10.8M....
What’s Next for Helicos(HLCS)?
Helicos made a timely entrance in the race for genetic analysis systems with their HeliScope "true single molecule sequencer" (tSMS), "the first DNA microscope". The technology was positioned as...